Back to Search
BENOIT MULSANT, MD
MD
Specialist
NPI: 1841264512Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
MD038640E(PA)
Clinical Trials (2)
2
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Age or age of onset: which is the best criterion to classify late-life depression?
PMID 36961017·Int Clin Psychopharmacol·2023
8-other
Association between lean muscle mass and treatment-resistant late-life depression in the IRL-GRey randomized controlled trial.
PMID 36594430·Int Psychogeriatr·2023
2-rct
Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome.
PMID 35771573·JAMA Netw Open·2022
3-trial
Coprescribed Benzodiazepines in Older Adults Receiving Antidepressants for Anxiety and Depressive Disorders: Association With Treatment Outcomes.
PMID 32991792·J Clin Psychiatry·2020
3-trial
Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History.
PMID 31846575·J Clin Psychiatry·2019
4-observational
Trajectories in Cerebral Blood Flow Following Antidepressant Treatment in Late-Life Depression: Support for the Vascular Depression Hypothesis.
PMID 30358242·J Clin Psychiatry·2018
3-trial
Clinical Predictors of Extrapyramidal Symptoms Associated With Aripiprazole Augmentation for the Treatment of Late-Life Depression in a Randomized Controlled Trial.
PMID 29924506·J Clin Psychiatry·2018
2-rct
Norepinephrine Transporter Gene Variants and Remission From Depression With Venlafaxine Treatment in Older Adults.
PMID 28068779·Am J Psychiatry·2017
4-observational
Gray matter regions statistically mediating the cross-sectional association of eotaxin and set-shifting among older adults with major depressive disorder.
PMID 27645461·Int J Geriatr Psychiatry·2017
8-other
Immunological biomarkers associated with brain structure and executive function in late-life depression: exploratory pilot study.
PMID 27282141·Int J Geriatr Psychiatry·2017
8-other
Predictors and Moderators of Remission With Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression: An Analysis of the IRL-GRey Randomized Clinical Trial.
PMID 26963689·JAMA Psychiatry·2016
4-observational
Trajectories of suicidal ideation in depressed older adults undergoing antidepressant treatment.
PMID 26708830·J Psychiatr Res·2016
8-other
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.
PMID 26423182·Lancet·2015
4-observational
Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.
PMID 26288246·JAMA Psychiatry·2015
2-rct
Depression Remission Rates Among Older Black and White Adults: Analyses From the IRL-GREY Trial.
PMID 26278231·Psychiatr Serv·2015
4-observational
Dynamic prediction of treatment response in late-life depression.
PMID 23567441·Am J Geriatr Psychiatry·2014
2-rct
What is the optimal duration of a short-term antidepressant trial when treating geriatric depression?
PMID 16633138·J Clin Psychopharmacol·2006
8-other
Review: pharmacotherapy provides minimal improvements in the neuropsychiatric symptoms of dementia.
PMID 16043625·Evid Based Ment Health·2005
8-other
Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.
PMID 15641877·J Clin Psychiatry·2004
3-trial
Achieving long-term optimal outcomes in geriatric depression and anxiety.
PMID 14978461·CNS Spectr·2003
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3811 OHARA ST, SUITE 1135-E
PITTSBURGH, PA 15213 - Phone
- (412) 624-1000
Quick Facts
- NPI
- 1841264512
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile